Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6488206 | 0.75 | — | — | |
| SCHEMBL27908834 | 0.75 | — | — | |
| SCHEMBL28820141 | 0.75 | — | — | |
| SCHEMBL30094463 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL27601354 | 0.72 | — | — | |
| SCHEMBL7138440 | 0.72 | PRCP (0.38) | — | |
| SCHEMBL19376306 | 0.72 | ATM (0.36) | — | |
| SCHEMBL7135646 | 0.71 | PRCP (0.33) | — | |
| SCHEMBL7144690 | 0.71 | JAK2 (0.30) | — | |
| SCHEMBL7135643 | 0.71 | PRCP (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102321092-B | Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer | UNIV TOKYO AGRICULTURE & TECHNOLOGY TLO CO LTD (JP) | 2015-01-14 | — | — | CN | claimed |
| US-20030195183-A1 | Method for correcting immune system of live body | ZHILOV VALERII KHAZHUMURATOVIC (RU) | 2003-10-16 | — | — | US | claimed |
| EP-1315497-A2 | AMINO DERIVATIVES OF 2,3-DIHYDROPHTALAZINE-1,4-DIONE AS IMMUNOCORRECTING AGENTS | Medinkor ZMM AG (CH) | 2003-06-04 | — | — | EP | claimed |
| WO-2002009681-A2 | A METHOD FOR CORRECTING THE IMMUNE SYSTEM OF LIVE BODY | MEDINKOR ZMM AG (CH) | 2002-02-07 | — | — | WO | claimed |
| CN-101346471-B | Triprenyl phenol compound, process for producing triisoprenyl phenol compound, and thrombolysis promoter | TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY TLO CO.,LTD. (JP) | 2016-01-06 | — | — | CN | disclosed |
| CN-102321092-B | Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer | UNIV TOKYO AGRICULTURE & TECHNOLOGY TLO CO LTD (JP) | 2015-01-14 | — | — | CN | disclosed |
| CN-102304131-B | Triprenyl phenol compound and its preparing method, and thrombolysis enhancer | NOKODAI TLO KK | 2014-07-16 | — | — | CN | disclosed |
| CN-101346471-A | Triprenyl phenol compound, process for producing triisoprenyl phenol compound, and thrombolysis promoter | UNIV TOKYO AGRICULTURE & TECHNOLOGY TLO CO LTD (JP) | 2009-01-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195183-A1 | Method for correcting immune system of live body | IL15, IL5, IL2 | HTR2A 1062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.